Product Recalls in Colorado

Product recalls affecting Colorado — including food, drugs, consumer products, medical devices, and vehicles distributed to Colorado. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,689 recalls have been distributed to Colorado in the last 12 months.

51,434 total recalls
2,689 in last 12 months

Showing 62216240 of 13,494 recalls

DrugNovember 30, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Amlodipine and Olmesartan Medoxomil Tablets Recalled by Aurobindo Pharma USA...

The Issue: Discoloration: This product is being recalled due to a confirmed pharmacist...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 5 mg/320 mg Recalled by Teva...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 10 mg/320 mg (a) 30-count bottles Recalled...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine Recalled by Teva Pharmaceuticals USA Due to CGMP Deviations: FDA...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine Recalled by Teva Pharmaceuticals USA Due to CGMP Deviations: FDA...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 10 mg/160 mg Recalled by Teva...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine Recalled by Teva Pharmaceuticals USA Due to CGMP Deviations: FDA...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Aprepitant Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: Shortfill: Aprepitant capsules 40 mg is being recalled due to customer...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine Recalled by Teva Pharmaceuticals USA Due to CGMP Deviations: FDA...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 5 mg/160 mg Recalled by Teva...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 26, 2018· Tris Pharma Inc.

Recalled Item: infants* IBUPROFEN Recalled by Tris Pharma Inc. Due to Superpotent Drug:...

The Issue: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 26, 2018· Tris Pharma Inc.

Recalled Item: Infants' Ibuprofen Recalled by Tris Pharma Inc. Due to Superpotent Drug:...

The Issue: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 26, 2018· Tris Pharma Inc.

Recalled Item: Infants' Ibuprofen Recalled by Tris Pharma Inc. Due to Superpotent Drug:...

The Issue: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 16, 2018· CAO Group, Inc.

Recalled Item: SHEER DesenZ Desensitizing Treatment Recalled by CAO Group, Inc. Due to cGMP...

The Issue: cGMP violations noted during the firm's most recent inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 16, 2018· CAO Group, Inc.

Recalled Item: BeeGentle Honey Flavored Topical Anesthetic Recalled by CAO Group, Inc. Due...

The Issue: cGMP violations noted during the firm's most recent inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 16, 2018· CAO Group, Inc.

Recalled Item: FastStat Topical Hemostat Introductory Kit Recalled by CAO Group, Inc. Due...

The Issue: cGMP violations noted during the firm's most recent inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 16, 2018· CAO Group, Inc.

Recalled Item: fas.TRACT Coagulative Hemostatic Gel Recalled by CAO Group, Inc. Due to cGMP...

The Issue: cGMP violations noted during the firm's most recent inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 15, 2018· Fresenius Kabi USA, LLC

Recalled Item: SODIUM CHLORIDE INJECTION Recalled by Fresenius Kabi USA, LLC Due to...

The Issue: Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 15, 2018· Fresenius Kabi USA, LLC

Recalled Item: SODIUM CHLORIDE INJECTION Recalled by Fresenius Kabi USA, LLC Due to...

The Issue: Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 14, 2018· Ascend Laboratories LLC

Recalled Item: Quetiapine Tablets USP 400 mg Recalled by Ascend Laboratories LLC Due to...

The Issue: Presence of Foreign Substance; metal shard found in tablet

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund